comparemela.com

Latest Breaking News On - Tyr pharma daily - Page 1 : comparemela.com

aTyr Pharma s (LIFE) Buy Rating Reiterated at HC Wainwright

aTyr Pharma s (LIFE) Buy Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

aTyr Pharma (NASDAQ:LIFE) Releases Earnings Results, Beats Estimates By $0 01 EPS

aTyr Pharma (NASDAQ:LIFE – Get Free Report) announced its earnings results on Thursday. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.01, Yahoo Finance reports. The firm had revenue of $0.24 million during the quarter, compared to analyst estimates of $0.11 million. aTyr Pharma […]

aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0 01 EPS

aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0 01 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Short Interest in aTyr Pharma, Inc (NASDAQ:LIFE) Rises By 167 4%

aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]

Short Interest in aTyr Pharma, Inc (NASDAQ:LIFE) Rises By 167 4%

aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.